Treatment of advanced/metastatic urothelial cancer has changed dramatically in recent years. This review discusses the use, risks, and benefits of several novel therapies for this indication.
Andrew T. Ruplin, PharmD
Advertisement
Articles by Andrew T. Ruplin, PharmD
Advertisement
Latest Updated Articles
Evolving Standards of Care in the Systemic Treatment of Metastatic Urothelial CancerPublished: July 14th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Modern Therapies Challenge Radiation’s Role in Early Breast Cancer Survival
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
Gedatolisib Triplet Shows Significant PFS Benefit in HR+/HER2– Breast Cancer
5
